Tag: generic drugs
Arlyn Ackerman
Batch Variability and Bioequivalence: What Acceptable Limits Really Mean
Batch variability in pharmaceutical manufacturing can skew bioequivalence results, leading to incorrect approvals or rejections of generic drugs. Learn how regulators are updating standards to account for real-world manufacturing differences.
Continue Reading
Arlyn Ackerman
Hospital Formulary Economics: How Institutions Choose Generic Drugs
Hospital formularies carefully select generic drugs based on clinical safety, cost, and supply reliability-not just price. Learn how P&T committees evaluate generics, navigate rebates, and manage shortages to ensure patient care isn't compromised.
Continue Reading